{
    "2021-12-12": [
        [
            {
                "time": "2023-11-15",
                "original_text": "Loxo Oncology at Lilly Announces Updated Data from the Phase 1/2 BRUIN Clinical Trial for Pirtobrutinib at the American Society of Hematology Annual Meeting",
                "features": {
                    "keywords": [
                        "Loxo Oncology",
                        "Lilly",
                        "Updated Data",
                        "Phase 1/2 BRUIN Clinical Trial",
                        "Pirtobrutinib",
                        "American Society of Hematology"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}